Search Results

More dietary supplements recalled

Source: Reactions, Volume 1, Number 1279, 2009-11-21 , pp. 2-2(1)

Publisher: Adis International

MHRA November update

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 3-3(1)

Publisher: Adis International

Body building dietary supplements found to contain steroids

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 4-4(1)

Publisher: Adis International

Certain lots of Tylenol [paracetamol, acetaminophen] Arthritis Pain Caplets are being voluntarily recalled in the US.

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 4-4(1)

Publisher: Adis International

All lots of ketorolac tromethamine injection USP 30 mg/mL distributed by American Regent have been voluntarily recalled in the US

Source: Reactions, Volume 1, Number 1276, 2009-10-31 , pp. 4-4(1)

Publisher: Adis International

Barr Laboratories, Inc., US, has issued a voluntary nationwide recall of a lot number of dexamfetamine/amfetamine 20mg tablets

Source: Reactions, Volume 1, Number 1266, 2009-08-22 , pp. 3-3(1)

Publisher: Adis International

The EMEA is recommending that market authorisation for dextropropoxyphene-containing medicines be withdrawn

Source: Reactions, Volume 1, Number 1259, 2009-07-04 , pp. 3-3(1)

Publisher: Adis International

All lots of phenobarbital 60mg tablets have been recalled in Canada after some oversized tablets were found in the Canadian market.

Source: Reactions, Volume 1, Number 1259, 2009-07-04 , pp. 3-3(1)

Publisher: Adis International

Four weight-loss products containing the undeclared pharmaceutical ingredient sibutramine are being withdrawn from the US market

Source: Reactions, Volume 1, Number 1262, 2009-07-25 , pp. 2-2(1)

Publisher: Adis International

The EMEA has agreed to a recall of all the remaining batches of efalizumab [Raptiva] from the European Union.

Source: Reactions, Volume 1, Number 1256, 2009-06-13 , pp. 3-3(1)

Publisher: Adis International

The US FDA warns against using Clarcon skin products after high levels of disease-causing bacteria were detected

Source: Reactions, Volume 1, Number 1256, 2009-06-13 , pp. 4-4(1)

Publisher: Adis International

Co-proxamol withdrawal has positive impact

Source: Reactions, Volume 1, Number 1258, 2009-06-27 , pp. 1-1(1)

Publisher: Adis International

EMD Serono Canada has withdrawn Raptiva [efalizumab] from the Canadian marketplace.

Source: Reactions, Volume 1, Number 1258, 2009-06-27 , pp. 2-2(1)

Publisher: Adis International

Ranbaxy has voluntarily recalled all lots of nitrofurantoin (monohydrate/macrocrystals) 100mg capsules from the US market

Source: Reactions, Volume 1, Number 1251, 2009-05-09 , pp. 3-3(1)

Publisher: Adis International

Genentech has announced a voluntary, phased withdrawal of its psoriasis drug efalizumab [Raptiva] from the US market

Source: Reactions, Volume 1, Number 1249, 2009-04-25 , pp. 2-2(1)

Publisher: Adis International

US FDA panel advises banning of two asthma drugs

Source: Reactions, Volume 1, Number 1238, 2009-02-07 , pp. 2-2(1)

Publisher: Adis International

EMEA recommends suspending Acomplia

Source: Reactions, Volume 1, Number 1226, 2008-11-01 , pp. 3-3(1)

Publisher: Adis International

EMEA recommends suspending Acomplia

Source: Inpharma, Volume 1, Number 1662, 2008-11-01 , pp. 22-22(1)

Publisher: Adis International

Public Citizen wants Avandia ban

Source: Reactions, Volume 1, Number 1227, 2008-11-08 , pp. 1-1(1)

Publisher: Adis International

Public Citizen wants Avandia ban

Source: Inpharma, Volume 1, Number 1663, 2008-11-08 , pp. 20-20(1)

Publisher: Adis International